TCI Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

TCI Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-379	Closed	-$14.2K	–	304
2023 Q1	$14.2K	Hold	379	–	–	﹤0.01%	881
2022 Q4	$10.6K	Hold	379	–	–	﹤0.01%	1035
2022 Q3	$11K	Sell	379 -100	-21%	-$3.27K	﹤0.01%	949
2022 Q2	$17K	Buy	479 +47	+11%	+$1.68K	﹤0.01%	697
2022 Q1	$16K	Buy	432 +53	+14%	+$1.5K	﹤0.01%	786
2021 Q4	$9K	Hold	379	–	–	﹤0.01%	1223
2021 Q3	$7K	Hold	379	–	–	﹤0.01%	1328
2021 Q2	$8K	Hold	379	–	–	﹤0.01%	1081
2021 Q1	$7K	Buy	+379	New	+$7.05K	﹤0.01%	1027
2019 Q4	–	Sell	-193	Closed	-$4K	–	1527
2019 Q3	$4K	Sell	193 -79	-29%	-$1.65K	﹤0.01%	844
2019 Q2	$6K	Sell	272 -40	-13%	-$836	﹤0.01%	717
2019 Q1	$6K	Sell	312 -22	-7%	-$493	﹤0.01%	725
2018 Q4	$7K	Sell	334 -12	-3%	-$237	﹤0.01%	694
2018 Q3	$7K	Buy	346 +59	+21%	+$1.05K	﹤0.01%	706
2018 Q2	$4K	Buy	+287	New	+$5.01K	﹤0.01%	819

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCI Wealth Advisors's AMPH Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2023, closing a stake of 379 shares — an estimated $14.2K sold.

TCI Wealth Advisors first reported a position in AMPH in Q2 2018 and held it in 15 quarters. The position peaked at $17K in Q2 2022. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

TCI Wealth Advisors reported no remaining Amphastar Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 379 Amphastar Pharmaceuticals shares in Q2 2023, an estimated $14.2K.
TCI Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2018 and held it in 15 quarters.
TCI Wealth Advisors's Amphastar Pharmaceuticals position peaked at $17K in Q2 2022.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.